Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Complete Response to Afatinib in Lung Adenocarcinoma of Epidermal Growth Factor Receptor Exon-19 Deletion Mutation and Disease Recurrence on Drug Discontinuation